Evaluate the National Animal Disease Control Programme's progress against FMD and Brucellosis, and the challenges that remain.
New · District CollectorCan you hold the district for 72 hours?Floods, a heatwave, an outbreak, a grievance queue. Take the decisions, see the consequences.Play →In this answer
Livestock are the "moving ATMs" of rural India, yet animal diseases cost the sector about ₹56,000 crore a year [1]. The Prime Minister launched the National Animal Disease Control Programme (NADCP) at Mathura in September 2019. It is a fully centrally funded scheme to control and eradicate Foot-and-Mouth Disease (FMD) and Brucellosis [2]. It has made clear progress, but eradication is still some way off.
Progress achieved
- Free mass vaccination at scale: over 147 crore FMD doses have been given free of cost [1].
- Results on the ground: FMD is being brought under control, and Brucellosis is reported to be under control [1].
- Steady funding: NADCP now sits under the Livestock Health & Disease Control Programme, which has ₹2,010 crore for 2026–27 [3].
- Home-grown vaccines: ICAR-NIHSAD's Brucella S-19 Delta vaccine is part of a wider push for self-reliance in veterinary vaccines [1].
Challenges that remain
- Losses are still large: FMD is still the costliest livestock disease at about ₹22,000 crore a year. Brucellosis costs about ₹9,212 crore [1].
- Control is not eradication: eradication is the stated goal [2]. Immunity from vaccines fades, so vaccination rounds must keep going until the virus stops circulating.
- Reaching every animal: India has many small, scattered herds. Keeping vaccines cold, finding enough trained vaccinators and keeping coverage even across states are all hard.
- Checking the results: "under control" is how the government describes it. Regular blood testing of herds (serosurveillance) and outbreak reporting are needed to confirm that animals are protected.
- Risk to humans: Brucellosis spreads to people, especially dairy workers. NADCP should therefore link up with human-health surveillance under a One Health approach.
- Narrow focus: Lumpy Skin Disease (about ₹20,000 crore) and PPR (about ₹4,683 crore) together cause losses almost as large as FMD and Brucellosis [1].
Verdict: NADCP has turned free mass vaccination into real gains against both diseases. The progress is solid but not yet complete. The next steps are:
- independent blood testing of herds;
- a stronger cold chain;
- more home-grown vaccines;
- One Health coordination.
With these, India can move from controlling the two diseases to eradicating them. That would protect smallholder incomes and help meet SDG 1 and SDG 2.
Sources
- 1PIB press release: Shivraj Singh Chouhan dedicates India's first indigenous H5N1 bird flu vaccine, 20 Nov 2026 (PIB)₹56,000 crore total losses; 147 crore+ FMD doses; FMD and Brucellosis control status; Brucella S-19 Delta; per-disease losses (FMD, Brucellosis, LSD, PPR)
- 2PIB: Prime Minister Launches National Animal Disease Control Programme and National Artificial Insemination Programme, 11 Sep 2019launch at Mathura; fully centrally funded; control and eradication of FMD and Brucellosis
- 3PIB backgrounder on NADCP/LHDCP, 22 Aug 2026₹2,010 crore LHDCP outlay for 2026–27
Practice
5 questions on this item
Check the answer for each question, or reveal all at once.